Documents
Application Sponsors
ANDA 203308 | MYLAN LABS LTD | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAVENOUS | 500MG/5ML (100MG/ML) | 0 | LEVETIRACETAM | LEVETIRACETAM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2016-09-16 | |
LABELING; Labeling | SUPPL | 2 | AP | 2020-04-20 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2020-04-20 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2020-04-20 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2022-03-08 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 17 |
SUPPL | 2 | Null | 7 |
SUPPL | 3 | Null | 7 |
SUPPL | 7 | Null | 15 |
SUPPL | 8 | Null | 15 |
TE Codes
CDER Filings
MYLAN LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 203308
[companyName] => MYLAN LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"500MG\/5ML (100MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/16\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/203308Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"04\/20\/2020","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"04\/20\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"04\/20\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-04-20
)
)